Photo courtesy of InterVenn Biosciences Philippines
MANILA – InterVenn Biosciences Philippines sees more than PHP500-million contribution to the Philippine economy this year, according to its founder and chief executive officer Aldo Carrascoso.
This, as the biotechnology innovator strengthens its presence in the Philippines and Southeast Asia by opening its office at Podium West Tower in Ortigas Center, Pasig City on Friday as part of the company’s expansion plans here.
"By the end of 2022, InterVenn would have brought over half a billion pesos into the Philippine economy,” Carrascoso said at the launching.
InterVenn is employing some 150 Filipinos in its local operations here since it was founded in 2017.
The company is a pioneer in pre-cancer screening by using artificial intelligence (AI).
“InterVenn has made significant progress in early cancer detection, thanks to the brilliant and dedicated Filipino engineers we have on board. They help build and maintain the front end, back end, and cloud infrastructure of our next-generation liquid biopsy, as we all work together to reach a world where no one should ever be blindsided by disease,” Carrascoso said.
InterVenn was one of the healthcare innovators that were met by the Department of Trade and Industry (DTI) delegation in San Francisco Bay Area and Silicon Valley last March.
The agency is aiming to lure more investments in the field of biotechnology into the country.
“One hundred percent of our software is proudly Philippine-made. We started this venture with the goal of not just having the means of finding a cure and early detection for cancer, but to also showcase to everyone that we Filipinos can achieve this on a global scale,” InterVenn Philippines general manager Axel Kornerup added. (PNA)
